NAEAP Symposium, Jan 1, 2020: Vets Consider 2.5% Polyacrylamide Gel (PAAG)Treatment
Report from NEAEP Symposium 2019 on the use of 2.5% PAAG
This article was Posted by Stephanie L. Church, Editor-in-Chief | Jan 1, 2020 | 2019 NEAEP Symposium, Arthritis & Degenerative Joint Disease, Arthritis & Degenerative Joint Disease, Article, Horse Care, Lameness, Older Horse Care Concerns.
In a “new uses for old things” twist, an equine veterinarian in Qatar, Dr Florent David, has reported that a 2.5% hydrogel originally designed as a cosmetic filler can help horses with early stage to chronic osteoarthritis (OA) and could even one day be used to help prevent joint damage.
Florent David, DVM, MS, Dipl. ACVS & ECVS, Dipl. ACVSMR, ECVDI Assoc., specialist in Surgery, Sports Medicine & Rehabilitation, and Diagnostic Imaging at the Equine Veterinary Medical Center, in Doha, described what he found in published research on the product at the 2019 Northeast Association of Equine Practitioners Symposium, held Sept. 25-27 in Saratoga Springs, New York.
Arthramid Vet New Zealand
Registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596. See www.foodsafety.govt.nz for registration conditions.